查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1917897

DNA合成仪市场－2026-2031年预测

DNA Synthesizer Market - Forecast from 2026 to 2031
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 128 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

DNA合成仪市场预计将从2025年的4.4063亿美元成长到2031年的10.24688亿美元，复合年增长率为15.1%。

DNA合成仪市场是生命科学工具产业中重要且快速发展的细分市场，为寡核苷酸和合成基因的人工合成和从头合成提供关键的设备和平台。这些自动化系统使研究人员能够根据数位输入建立客製化的DNA序列，从而为包括合成生物学、治疗方法开发和分子诊断在内的广泛应用奠定基础。该市场的特点是技术从传统的亚磷酰胺化学转变为新型酶法转变，桌上型自动化技术的进步，以及与高通量工业工作流程的日益整合。推动市场成长的因素包括：合成生物学的广泛应用和不断增长的需求、药物研发流程的加速推进，以及对更快、更便捷、更精确的DNA建构方法的需求。

推动合成生物学发展的主要动力之一是对合成生物学研究及其商业应用的大量且不断增长的投资。合成生物学致力于设计和建构新的生物构件和系统，根本在于能够像读取DNA一样轻鬆地编写DNA。其应用范围广泛，涵盖了从用于工业生物技术和农业的工程微生物到新型疫苗、细胞和基因疗法以及基于DNA的数据存储的开发。该领域的扩张正在创造对合成DNA的持续且巨大的需求，从而推动了对更高通量、更长构建时间和更低错误率的合成设备的需求，以支持日益雄心勃勃的计划。

与此密切相关的是DNA合成在现代药物发现和治疗方法开发中的关键作用。製药和生物技术产业高度依赖客製化DNA进行标靶检验、抗体开发、CRISPR引导RNA合成以及基因治疗病毒载体建构。 mRNA疗法和疫苗的兴起进一步加剧了这种需求，因为这些治疗方法需要精确合成长链、序列优化的RNA模板。 DNA合成仪是加速研发进程的关键工具，因此需要能够无缝整合到自动化、高通量工作流程中的平台，以提高药物开发平臺的效率并缩短週期。

桌上型DNA合成仪的需求不断成长，技术也日趋创新，这是市场的关键趋势。传统上，DNA合成要么在大型集中式核心实验室进行，要么外包给服务供应商。而紧凑易用的桌上型仪器的出现，使得合成过程分散化，将寡核苷酸的生产直接引入学术界、生物技术和製药实验室。这些系统为研究人员提供了即时、按需获取客製化寡核苷酸的途径，显着加快了实验迭代速度，并保护了智慧财产权。这种实验室规模自动化的趋势，使合成能力惠及更广泛的终端使用者群体，从而扩大了潜在市场。

技术创新，尤其是酶促DNA合成（EDS）的出现，代表市场潜在的模式转移。固相亚磷酰胺化学方法几十年来一直是行业标准，但酶方法展现出许多优势，包括减少有害溶剂的使用、实现更长时间、更精确的合成，以及为更环保的生产方式铺平道路。开发EDS平台的公司正着眼于实验室规模和可扩展的工业应用，将这项技术定位为颠覆性创新，并有望在未来几年内重新定义合成的经济性和能力。

此外，合成DNA在分子诊断和个人化医疗领域的应用日益广泛，推动了市场的发展。客製化寡核苷酸是PCR检测、次世代定序平台和各种诊断探针的关键组成部分。随着精准医疗的进步和分子诊断项目的扩展，可靠且经济高效地合成这些特定DNA序列的需求日益增长，从而满足了诊断领域持续增长的需求。

从区域来看，北美保持着市场主导地位。这一主导地位得益于该地区聚集了众多大型生物技术和製药公司、顶尖学术研究机构，为合成生物学Start-Ups提供了充足的创业投资投资，以及成熟的生命科学创新生态系统。众多大型合成设备製造商的存在，加上该地区积极采用新技术的文化，进一步巩固了北美作为先进DNA合成平台领先市场的地位。

竞争格局包括提供亚磷酰胺基设备的成熟公司、开创酶促合成新兴企业的创新新创企业，以及开发专有合成技术的大型服务供应商。竞争的焦点在于关键性能指标：合成速度、通量、长序列定序能力（读取长度和通量）、序列准确性（错误率）、碱基成本以及与实验室自动化系统的整合便捷性。策略活动通常涉及与製药和合成生物学公司合作，共同开发客製化解决方案。

总之，DNA合成仪市场正从寡核苷酸生产的利基工具转型为支持蓬勃发展的生物经济的核心技术。其成长轨迹与合成生物学的扩张以及生物数位化在治疗方法和诊断领域的进步密不可分。未来市场发展将受到酵素合成技术的成功商业化和规模化、桌上型系统的持续小型化和自动化，以及产业降低成本和提高长DNA构建体保真度的能力等因素的影响。市场参与企业的成功取决于其能否提供可靠、扩充性且以用户为中心的平台，使研究人员能够以前所未有的速度和精度将基因设计转化为物理现实。

本报告的主要优势：

  • 深入分析：取得以客户群、政府政策和社会经济因素、消费者偏好、垂直产业和其他细分市场为重点的深入市场洞察，涵盖主要地区和新兴地区。
  • 竞争格局：了解主要企业采取的策略倡议，并了解透过正确的策略打入市场的潜力。
  • 市场驱动因素与未来趋势：探索动态因素和关键市场趋势，以及它们将如何塑造未来的市场发展。
  • 可执行的建议：利用洞察力为策略决策提供讯息，从而在动态环境中开拓新的业务管道和收入来源。
  • 受众范围广：对新兴企业、研究机构、顾问公司、中小企业和大型企业都有益处且经济高效。

它是用来做什么的？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范及影响、新产品开发、竞争影响

分析范围

  • 历史资料（2021-2025 年）和预测资料（2026-2031 年）
  • 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
  • 竞争对手定位、策略和市场占有率分析
  • 按业务板块和地区（国家）分類的收入成长和预测分析
  • 公司概况（策略、产品、财务资讯、关键趋势等）

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 分析范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策和法规
  • 策略建议

第四章 技术展望

第五章 DNA合成仪市场：依类型划分

  • 介绍
  • 桌上型DNA合成器
  • 大型DNA合成器

第六章 DNA合成仪市场：依应用领域划分

  • 介绍
  • 药物发现
  • 基因工程
  • 临床诊断
  • 其他的

第七章 DNA合成仪市场（依最终用户划分）

  • 介绍
  • 製药和生物技术公司
  • 学术和研究机构
  • 其他的

第八章 DNA合成仪市场（按地区划分）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第九章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 企业合併、协议、商业合作
  • 竞争对手仪錶板

第十章：公司简介

  • Kilobaser
  • DNA Script SAS
  • CSBio
  • Telesis Bio
  • Eurofins Genomics LLC
  • Honya Biotech
  • Thermo Fisher Scientific
  • Danaher Corporation
  • Bioneer Corporation
  • LGC Biosearch Technologies

第十一章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 分析方法
  • 简称
简介目录
Product Code: KSI061615960

DNA Synthesizer Market is projected to expand at a 15.1% CAGR, attaining USD 1024.688 million in 2031 from USD 440.630 million in 2025.

The DNA synthesizer market is a critical and rapidly evolving segment within the life sciences tools industry, providing the instrumentation and platforms essential for the artificial, de novo creation of oligonucleotides and synthetic genes. These automated systems enable researchers to construct custom DNA sequences from digital inputs, forming the foundational material for a vast range of applications in synthetic biology, therapeutic development, and molecular diagnostics. The market is characterized by a technological shift from traditional phosphoramidite chemistry toward novel enzymatic methods, a move toward benchtop automation, and increasing integration into high-throughput industrial workflows. Growth is driven by the expansive and growing needs of synthetic biology, accelerating drug discovery pipelines, and the demand for faster, more accessible, and higher-fidelity DNA construction.

A primary and powerful driver is the substantial and rising investment in synthetic biology research and its commercial applications. Synthetic biology, which involves the design and construction of new biological parts and systems, is fundamentally dependent on the ability to write DNA as readily as it can be read. Applications span from engineered microbes for industrial biotechnology and agriculture to the development of novel vaccines, cell and gene therapies, and DNA-based data storage. The expansion of this field creates sustained, high-volume demand for synthetic DNA, pushing the need for synthesizers that offer greater throughput, longer construct lengths, and lower error rates to support increasingly ambitious projects.

Closely aligned is the critical role of DNA synthesis in modern drug discovery and therapeutic development. The pharmaceutical and biotechnology industries rely heavily on custom DNA for target validation, antibody development, CRISPR guide RNA synthesis, and the construction of viral vectors for gene therapy. The rise of mRNA therapeutics and vaccines has further amplified this demand, as these modalities require the precise synthesis of long, sequence-optimized RNA templates. DNA synthesizers are integral tools for accelerating these R&D timelines, creating demand for platforms that integrate seamlessly into automated, high-throughput workflows to improve productivity and reduce cycle times in drug development pipelines.

A significant market trend is the growing demand for and innovation in benchtop DNA synthesizers. Traditionally, DNA synthesis was performed by large, centralized core facilities or outsourced to service providers. The advent of compact, user-friendly benchtop instruments is decentralizing synthesis, bringing oligo production directly into individual academic, biotech, and pharmaceutical labs. These systems offer researchers immediate, on-demand access to custom oligonucleotides, significantly speeding experimental iteration and protecting intellectual property. This trend toward lab-scale automation is expanding the total addressable market by placing synthesis capability in the hands of a broader base of end-users.

Technological innovation, particularly the emergence of enzymatic DNA synthesis (EDS), represents a potential paradigm shift within the market. While solid-phase phosphoramidite chemistry has been the industry standard for decades, enzymatic methods offer promising advantages, including reduced use of hazardous solvents, the potential for longer and more accurate synthesis, and a pathway to greener manufacturing. Companies developing EDS platforms are targeting both benchtop and scalable industrial applications, positioning this technology as a key disruptive force that could redefine synthesis economics and capabilities in the coming years.

The market is further fueled by the expanding application of synthetic DNA in molecular diagnostics and personalized medicine. Custom oligonucleotides are essential components for PCR assays, next-generation sequencing panels, and various diagnostic probes. As precision medicine advances and the menu of molecular diagnostics grows, so does the need for reliable, cost-effective synthesis of these specific DNA sequences, supporting steady demand from the diagnostics sector.

Geographically, North America maintains a dominant market position. This leadership is anchored in the region's concentration of leading biotechnology and pharmaceutical companies, top-tier academic research institutions, substantial venture capital funding for synthetic biology startups, and a mature ecosystem for life sciences innovation. The presence of many key synthesizer manufacturers and a culture of early technology adoption further reinforce North America's role as the primary market for advanced DNA synthesis platforms.

The competitive landscape includes established providers of phosphoramidite-based instrumentation, innovative startups pioneering enzymatic synthesis, and large-scale service providers that also develop proprietary synthesis technologies. Competition centers on key performance metrics: synthesis speed, throughput, length capability (read length and throughput), sequence accuracy (error rate), cost per base, and ease of integration into laboratory automation. Strategic activities often involve partnerships with pharmaceutical companies or synthetic biology firms to co-develop tailored solutions.

In conclusion, the DNA synthesizer market is transitioning from a niche tool for oligo production to a central enabling technology for the burgeoning bioeconomy. Its growth trajectory is inextricably linked to the expansion of synthetic biology and the increasing biological digitization of therapeutics and diagnostics. Future market development will be shaped by the successful commercialization and scaling of enzymatic synthesis, continued miniaturization and automation of benchtop systems, and the industry's ability to drive down the cost and increase the fidelity of long DNA constructs. Success for market participants will depend on delivering reliable, scalable, and user-centric platforms that empower researchers to translate genetic designs into physical reality with unprecedented speed and precision.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

DNA Synthesizer Market Segmentation

  • By Type
  • Benchtop DNA Synthesizer
  • Large-Scale DNA Synthesizer
  • By Application
  • Drug Discovery
  • Genetic Engineering
  • Clinical Diagnostics
  • Others
  • By End-User
  • Pharmaceutical & Biotech Companies
  • Academic & Research Institutes
  • Others
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations
  • 3.8. Products in Pipeline

4. TECHNOLOGICAL OUTLOOK

5. DNA SYNTHESIZER MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Benchtop DNA Synthesizer
  • 5.3. Large-Scale DNA Synthesizer

6. DNA SYNTHESIZER MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Drug Discovery
  • 6.3. Genetic Engineering
  • 6.4. Clinical Diagnostics
  • 6.5. Others

7. DNA SYNTHESIZER MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Pharmaceutical & Biotech Companies
  • 7.3. Academic & Research Institutes
  • 7.4. Others

8. DNA SYNTHESIZER MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Kilobaser
  • 10.2. DNA Script SAS
  • 10.3. CSBio
  • 10.4. Telesis Bio
  • 10.5. Eurofins Genomics LLC
  • 10.6. Honya Biotech
  • 10.7. Thermo Fisher Scientific
  • 10.8. Danaher Corporation
  • 10.9. Bioneer Corporation
  • 10.10. LGC Biosearch Technologies

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations